STAAR Surgical Company designs, develops, manufactures, and sells implantable lenses for the eye and accessory delivery systems used to deliver the lenses into the eye. The Company markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The Company's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). It also markets and sells an ICL lens to treat hyperopia (farsightedness), called Visian ICL. It makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company's principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Back to dashboard
Company Information
About this company
Key people
Neal C. Bradsher
Independent Chairman of the Board
Louis E. Silverman
Independent Director
Warren Foust
President, Chief Executive Officer, Director
Deborah J. Andrews
Chief Financial Officer, Executive Vice President
Ben Park
Chief Technology Officer
David Bailey
Chief Commercial Officer
Magda Michna
Chief Development Officer
Wei Jiang
Director
Arthur Crosswell Butcher
Independent Director
Richard T. LeBuhn
Independent Director
Click to see more
Key facts
- Shares in issue50.52m
- EPICSTAA
- ISINUS8523123052
- LocationUnited States
- SectorHealthcare
- IndustryMedical Equipment & Supplies
- Market cap$1.13bn
- Employees957
- ExchangeNASDAQ
- IndexS&P 600 Small Cap, TR Equity United States Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.